ABBV Stock Recent News

ABBV LATEST HEADLINES

ABBV Stock News Image - youtube.com

CNBC's Angelica Peebles joins 'The Exchange' to discuss President Trump posting letters to 17 pharmaceutical companies about drug prices.

youtube.com 2025 Jul 31
ABBV Stock News Image - cnbc.com

President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a controversial policy that aims to slash drug costs by tying the prices of some medicine in the U.S. to the significantly lower ones abroad.

cnbc.com 2025 Jul 31
ABBV Stock News Image - marketbeat.com

AbbVie Inc. NYSE: ABBV stock is up nearly 2% in midday trading after delivering a beat-and-raise in its second-quarter 2025 earnings report. The biopharmaceutical giant reported global net revenue of $15.42 billion, beating expectations for $14.93 billion.

marketbeat.com 2025 Jul 31
ABBV Stock News Image - zacks.com

ABBV tops Q2 forecasts and lifts 2025 EPS outlook as Rinvoq and Skyrizi drive growth amid Humira's decline.

zacks.com 2025 Jul 31
ABBV Stock News Image - zacks.com

PCE Comes in Warmer Than Expected.

zacks.com 2025 Jul 31
ABBV Stock News Image - zacks.com

Pre-market and bond yield numbers appear to be in reaction to this morning's economic posts.

zacks.com 2025 Jul 31
ABBV Stock News Image - zacks.com

While the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com 2025 Jul 31
ABBV Stock News Image - zacks.com

AbbVie (ABBV) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.89 per share. This compares to earnings of $2.65 per share a year ago.

zacks.com 2025 Jul 31
ABBV Stock News Image - barrons.com

Second quarter EPS came in at $2.97 on revenue of $15.4 billion, beating analysts expectations.

barrons.com 2025 Jul 31
ABBV Stock News Image - reuters.com

AbbVie raised its 2025 profit forecast on Thursday, after beating Wall Street estimates for second-quarter results on strong sales of its newer immunology drugs Skyrizi and Rinvoq.

reuters.com 2025 Jul 31
10 of 50